Suvretta Capital Management, LLC Gilead Sciences, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.33 Billion
- Q1 2024
A detailed history of Suvretta Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 50,700 shares of GILD stock, worth $3.48 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
50,700
Previous 22,700
123.35%
Holding current value
$3.48 Million
Previous $1.84 Million
102.01%
% of portfolio
0.16%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,884Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.41 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.87 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.8 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.2 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.96 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $86B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...